Kari Zich
Nurse Practitioner · Rochester, MNNPI 1083255228
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,040 of the $4,313 with a category attached, or 70.5%. It is spread thinly across 22 manufacturers, the largest accounting for just 20.9%. Reporting peaked in 2023 at $1,705 and has fallen 85.8% since, to $242 in 2025. Among nurse practitioner clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $62.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fresenius Kabi USA, LLC$900
- Myriad Genetic Laboratories, Inc.$813
- Lilly USA, LLC$545
- Merck$273
- AstraZeneca$231
- Gilead$228
- plus $1K from 16 others
What the payments were for
- Consulting fees$67516%
- Food & beverage$3,04070%
- Education$59814%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fresenius Kabi USA, LLC | 2 | $900 |
| Myriad Genetic Laboratories, Inc. | 12 | $813 |
| Lilly USA, LLC | 10 | $545 |
| Merck | 12 | $273 |
| AstraZeneca | 6 | $231 |
| Gilead | 4 | $228 |
| Tactile Systems Technology Inc | 2 | $180 |
| Daiichi Sankyo Inc. | 2 | $145 |
| Regeneron Healthcare Solutions, Inc. | 1 | $133 |
| Puma Biotechnology, Inc. | 1 | $129 |
| Exelixis Inc. | 1 | $125 |
| Jazz Pharmaceuticals Inc. | 1 | $125 |
| Seagen Inc. | 2 | $119 |
| Genentech USA, Inc. | 1 | $104 |
| Eisai Inc. | 3 | $67 |
| Genmab U.S., Inc. | 2 | $49 |
| Johnson & Johnson(2 entities) | 2 | $39 |
| AbbVie | 1 | $30 |
| GSK | 1 | $22 |
| Pfizer | 1 | $19 |
| GE HealthCare | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,313 in reported general payments places this provider in the 95th percentile of 3,021 nurse practitioner providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 481 | $9,366 |
| Exemestane | 41 | $7,025 |
| Letrozole | 97 | $1,651 |
| Tamoxifen Citrate | 26 | $988 |
| Alendronate Sodium | 61 | $617 |
| Gabapentin | 47 | $480 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Rochester
- Kimberly ThompsonRochester$62K
- Jamie CarrollRochester$18K
- Lisa ChristensonRochester$15K
- Jamie HaradenRochester$12K
- Brooke SukalskiRochester$12K
- Lucy HolmesRochester$11K
- Katie BenikeRochester$9K
- Lisa KottschadeRochester$9K
- Elizabeth AndersonRochester$5K
- Karen HansonRochester$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.